Search - tctmd.com

Displaying 1 - 10 of 10

Sort: Relevancy | Date

Colchicine Surprise: No Help Post-MI, Large CLEAR SYNERGY Trial Shows

News Conference News TCT 2024

Colchicine Surprise: No Help Post-MI, Large CLEAR SYNERGY Trial Shows

Michael O'Riordan

October 29, 2024

FDA Approves First New PET Imaging Tracer for Cardiac Testing in Decades

News Daily News

FDA Approves First New PET Imaging Tracer for Cardiac Testing in Decades

October 02, 2024

Low Adherence to Secondary Prevention Recommendations Worldwide: INTERASPIRE

News Daily News

Low Adherence to Secondary Prevention Recommendations Worldwide: INTERASPIRE

Yael L. Maxwell

September 23, 2024

Debating a PCI-First Strategy in Stable CAD: ORBITA-2 vs the Unconvinced

News Daily News

Debating a PCI-First Strategy in Stable CAD: ORBITA-2 vs the Unconvinced

Michael O'Riordan

September 20, 2024

ESC’s 2024 CCS Guidelines Embrace New Data, Smooth Old Tensions

News Conference News ESC 2024

ESC’s 2024 CCS Guidelines Embrace New Data, Smooth Old Tensions

Michael O'Riordan

September 17, 2024

Stressors From All Sides Impact Women’s CV Risk, Review Asserts

News Daily News

Stressors From All Sides Impact Women’s CV Risk, Review Asserts

July 10, 2024

Let’s Talk About Sex: How Best to Broach Post-MI Conversations

News Features

Let’s Talk About Sex: How Best to Broach Post-MI Conversations

June 14, 2024

Certain Periprocedural MIs Don’t Matter, New Data Allege

News Daily News

Certain Periprocedural MIs Don’t Matter, New Data Allege

Michael O'Riordan

May 09, 2024

$Coronary Sinus Reducer Eases Symptoms in Refractory Angina: ORBITA-COSMIC$

News Conference News ACC 2024

Coronary Sinus Reducer Eases Symptoms in Refractory Angina: ORBITA-COSMIC

Michael O'Riordan

April 08, 2024

Real-world Data Reiterate Value of CT-First Strategy to Rule Out Obstructive CAD

News Conference News

Real-world Data Reiterate Value of CT-First Strategy to Rule Out Obstructive CAD

February 02, 2024

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.